Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Minkyung Ko
Institution:
International Vaccine Institute
Observed institutions:
International Vaccine Institute,
Korean Association Of Science and Technology Studies,
Korea Institute of Science and Technology
ORCID:
0000-0003-1314-7952
Observed ORCID:
0000-0003-1314-7952
OpenAlex ID:
A5047356349
TIGIT/CD226 Axis Regulates Anti-Tumor Immunity
2021
·
Jinah Yeo
, Minkyung Ko
, et al.
·
Pharmaceuticals
·
144
PDF
CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy
2020
·
Hyung-seung Jin
, Minkyung Ko
, et al.
·
Cancer Immunology Research
·
89
LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation
2022
·
Eunsil Sung
, Minkyung Ko
, et al.
·
Molecular Therapy
·
84
PDF
Extracellular pH modulating injectable gel for enhancing immune checkpoint inhibitor therapy
2019
·
Hyung-seung Jin
, Da-som Choi
, et al.
·
Journal of Controlled Release
·
39
PDF
Genome wide CRISPR screening reveals a role for sialylation in the tumorigenesis and chemoresistance of acute myeloid leukemia cells
2021
·
Dong-hee Lee
, Seong-Ho Kang
, et al.
·
Cancer Letters
·
26
Novel pyrimidoazepine analogs as serotonin 5-HT2A and 5-HT2C receptor ligands for the treatment of obesity
2013
·
Ha Yun Yang
, Jinsung Tae
, et al.
·
European Journal of Medicinal Chemistry
·
24
Abstract 1633: ABL501, PD-L1 x LAG-3, a bispecific antibody promotes enhanced human T cell activation through targeting simultaneously two immune checkpoint inhibitors, LAG-3 and PD-L1
2021
·
Eunyoung Park
, Hyunejoo Kim
, et al.
·
Cancer Research
·
4
Establishment of a Cynomolgus Macaque Model for Human Adenovirus Type 55–Induced Respiratory Disease
2025
·
Sang Hwan Seo
, Jung-ah Choi
, et al.
·
The Journal of Infectious Diseases
·
3
An inactivated human adenovirus type 55 vaccine attenuates pulmonary pathology in a non-human primate challenge model
2026
·
Jun Young Lee
, Jung-ah Choi
, et al.
·
Virus Research
Data from CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy
2023
·
Hyung-seung Jin
, Minkyung Ko
, et al.
Data from CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy
2023
·
Hyung-seung Jin
, Minkyung Ko
, et al.
Supplementary Figures from CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy
2023
·
Hyung-seung Jin
, Minkyung Ko
, et al.
Show more works
View as search
Works count:
12
Citation count:
419
H-index:
6
I10-index:
6
Year
Topic
Type